{"blocks": [{"key": "c8bc6717", "text": "Scenario", "type": "header-two", "depth": 0, "inlineStyleRanges": [], "entityRanges": [], "data": {}}, {"key": "c2253082", "text": "Evaluating two treatments (t1, t2) on Gross Booking (GB) and Variable Consideration (VC)", "type": "unstyled", "depth": 0, "inlineStyleRanges": [], "entityRanges": [], "data": {}}, {"key": "54659c0b", "text": "Question", "type": "header-two", "depth": 0, "inlineStyleRanges": [], "entityRanges": [], "data": {}}, {"key": "1adf3477", "text": "Treatment t1 shows no significant change in GB or VC, while t2 shows a significant increase in GB but a significant decrease in VC. How would you explain these results to the PM and recommend next steps? Given confidence intervals GB [+0.1%, +2.3%] with +$0.48 lift, and VC [-2.5%, -1.5%] with -$0.20 loss, would you launch t2? Justify your decision. How would you segment users or orders to identify cohorts with positive GB impact and no negative VC impact? If 20 different experiments run simultaneously, how would you define launch criteria to control false discoveries and ensure reliable decisions?", "type": "unstyled", "depth": 0, "inlineStyleRanges": [], "entityRanges": [], "data": {}}, {"key": "eee2c398", "text": "Hints", "type": "header-two", "depth": 0, "inlineStyleRanges": [], "entityRanges": [], "data": {}}, {"key": "1c104dc6", "text": "Discuss trade-offs, statistical power, cost-benefit, cohort analysis, multiple-testing corrections (e.g., FDR).", "type": "unstyled", "depth": 0, "inlineStyleRanges": [], "entityRanges": [], "data": {}}], "entityMap": {}}